Cargando…
Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
Vaccination against SARS-CoV-2 to prevent COVID-19 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs). Little is known about the effect of booster vaccination or infection followed by previously completed two-dose vaccination in aiRMD...
Autores principales: | Honfi, Dániel, Gémes, Nikolett, Szabó, Enikő, Neuperger, Patrícia, Balog, József Á., Nagy, Lajos I., Toldi, Gergely, Puskás, László G., Szebeni, Gábor J., Balog, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569441/ https://www.ncbi.nlm.nih.gov/pubmed/36232710 http://dx.doi.org/10.3390/ijms231911411 |
Ejemplares similares
-
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study
por: Szebeni, Gábor J., et al.
Publicado: (2022) -
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
por: Szabó, Enikő, et al.
Publicado: (2023) -
Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model
por: Szebeni, Gábor J., et al.
Publicado: (2023) -
Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
por: Szalontai, Klára, et al.
Publicado: (2021) -
A cytotoxic survey on 2‐amino‐1H‐imidazol based synthetic marine sponge alkaloid analogues
por: Gémes, Nikolett, et al.
Publicado: (2022)